Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/16/1991 | EP0451182A1 Pharmaceutical formulations. |
10/16/1991 | EP0437479A4 Method of making liposomes with improved stability during drying |
10/16/1991 | EP0436667A4 Biodegradable in-situ forming implants |
10/16/1991 | EP0229810B1 Protection of proteins and the like |
10/16/1991 | EP0210269B1 X-ray-emitting interstitial implants |
10/16/1991 | CN1055355A Stablizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide-containing preparation, stabilizing method therefor and drug stabilized thereby |
10/16/1991 | CN1055298A Stable microbubbles suspensions injectable into living organisms |
10/16/1991 | CN1055294A Encasing effective material with starch |
10/16/1991 | CN1055293A Stable compositions for parenteral administration and method of making same |
10/16/1991 | CN1055285A Multiple encapsulated flavor delivery system and method of preparation |
10/15/1991 | US5057541 Composition for external application |
10/15/1991 | US5057518 Pharmaceutical preparations |
10/15/1991 | US5057319 Pharmaceutical compositions of cimetidine |
10/15/1991 | US5057317 Slow-release pharmaceutical agent |
10/15/1991 | US5057313 Diagnostic and therapeutic antibody conjugates |
10/15/1991 | US5057302 Bifunctional chelating agents |
10/15/1991 | US5057301 Fluorinated sugars |
10/15/1991 | CA1290695C Pharmaceutical composition for periodontal diseases |
10/15/1991 | CA1290690C Method of reducing the swelling or pain associated with antibiotics compositions |
10/11/1991 | CA2040116A1 Sustained release of active agents from bioadhesive microcapsules |
10/10/1991 | DE4010876A1 Waessrige tensidmischungen mit guter hautvertraeglichkeit Aqueous surfactant mixtures with good hautvertraeglichkeit |
10/10/1991 | DE4010536A1 Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure A pharmaceutical aqueous solution of 4- (2- (benzenesulfonylamino) ethyl) -phenoxyacetic acid |
10/09/1991 | EP0450986A2 A percutaneous-administration-type pharmaceutical preparation of nitroglycerin |
10/09/1991 | EP0450800A1 Utilization and delivery of enzymes |
10/09/1991 | EP0450628A1 Saccharide-modified, watersoluble proteins |
10/09/1991 | EP0450597A2 Cosmetic gel stick compositions |
10/09/1991 | EP0450479A1 Bispecific monoclonal anti-bodies, their production and use |
10/09/1991 | EP0450262A1 Pharmaceutical preparation with delayed drug release |
10/09/1991 | EP0450176A1 Polymers containing sugar for the encapsulation and incorporation of drugs |
10/09/1991 | EP0450141A1 Carrier material for administration of drugs |
10/09/1991 | EP0450123A1 Pharmaceutical composition for topical administration containing diclofenac-sodium |
10/09/1991 | EP0450117A1 Ringers solution and its use as a bactericidally active local wound-treatment medicament |
10/09/1991 | EP0450094A1 Hydrophilic polymer-silicate mineral composite and its use |
10/09/1991 | EP0450080A1 Composition for the treatment of progressive myopia |
10/09/1991 | EP0449998A1 Antibody-oxidase conjugates with non-systemic substrates |
10/09/1991 | EP0449973A1 Polypeptide-polymer conjugates active in wound healing. |
10/09/1991 | CN1055110A Pharmaceutical solution |
10/08/1991 | US5055562 Fluorocarbon chain-containing antigenic conjugates |
10/08/1991 | US5055561 Protein label and drug delivery system |
10/08/1991 | US5055461 Acid salt of aminopropiopheneone, oral anesthetic, saccharin, carrier; stability |
10/08/1991 | US5055306 Sustained-release formulations |
10/08/1991 | US5055304 Containing disodium adenosine triphosphate and low melting fat or oil-like component; cardiovascular disorders, asthenopia |
10/08/1991 | US5055291 Compositions for preventing secondary cataracts |
10/08/1991 | US5055289 Dual specificity against therapeutically active agent and against a disease related antigen |
10/08/1991 | US5055171 Nonporous solid composite encapsulating metallic electrode |
10/08/1991 | CA1290267C Human anti-inflammatory phospholipase inhibitor protein |
10/08/1991 | CA1290251C Spray dried acetaminophen |
10/07/1991 | WO1991015205A1 Solid oral preparation containing catechol compound |
10/07/1991 | CA2056405A1 Solid oral preparation containing catechol compound |
10/06/1991 | WO1991015117A1 Film-forming proteinaceous emulsion |
10/06/1991 | CA2079900A1 Film-forming proteinaceous emulsion |
10/03/1991 | WO1991014729A1 Film-forming product intended for coating solid forms |
10/03/1991 | WO1991014463A1 Method and device for the release of drugs to the skin |
10/03/1991 | WO1991014456A2 Improved compositions for photodynamic therapy |
10/03/1991 | WO1991014455A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
10/03/1991 | WO1991014454A1 Pharmaceutical formulations |
10/03/1991 | WO1991014434A1 Multi-functional pharmaceutical compounds and methods of use |
10/03/1991 | WO1991014429A1 Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use |
10/03/1991 | WO1991014425A1 Process for producing solid active substance forms and products so obtained |
10/03/1991 | WO1991014422A1 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
10/03/1991 | CA2079233A1 Pharmaceutical formulations |
10/03/1991 | CA2039457A1 Ringer's solution |
10/03/1991 | CA2039259A1 Bispecific monoclonal antibodies, their production and use |
10/02/1991 | EP0449731A1 Anti-inflammatory and/or analgesic pharmaceutical composition for perlingual administration |
10/02/1991 | EP0449592A1 Bioelastomeric drug delivery system |
10/02/1991 | EP0449463A2 Method and composition for iontophoresis |
10/02/1991 | EP0449167A1 Process for preparing piroxicam/cyclodextrin complexes, the products obtained and their pharmaceutical compositions |
10/02/1991 | EP0448930A1 Stable compositions for parenteral administration and method of making same |
10/02/1991 | EP0448895A1 Use of a non-alcoholic delivery system for active ingredients which are ingested orally |
10/02/1991 | EP0448856A1 Ophthalmic preparations comprising timolol maleate |
10/02/1991 | EP0448605A1 Use of basic amino acids to solubilize immunoglobulins |
10/02/1991 | EP0228458B1 Epithelial cells expressing foreign genetic material |
10/02/1991 | DE4009984A1 Verfahren zur herstellung fester wirkstoff-formen und die so erhaltenen produkte Process for producing solid drug forms, and the products thus obtained |
10/01/1991 | US5053490 Storage stability |
10/01/1991 | US5053453 Protein covalently bound to support material |
10/01/1991 | US5053423 Compositions for photodynamic therapy |
10/01/1991 | US5053394 Protein-drug reaction product |
10/01/1991 | US5053387 Feeding fish oil to reduce hypermetabolic state |
10/01/1991 | US5053341 Tissue simulating gel for medical research |
10/01/1991 | US5053228 Polymeric temperature sensitive drug carrier |
10/01/1991 | US5053227 Transmittance of drug in mixture of diethylene glycol ethyl and/or methyl ether and ester |
10/01/1991 | US5053226 Monoclonal antibodies binding platinum complexes |
10/01/1991 | CA2038969A1 Compositions comprising cytotoxic agent and permeation enhancers |
10/01/1991 | CA2027447A1 Glycosaminoglycan-modified protein |
10/01/1991 | CA1289888C Therapeutic or cosmetic composition in the form of a liquid solution from essentially anhydroux oxygen peroxide |
10/01/1991 | CA1289886C Solutions of oxazaphosphorins having improved stability and process for the preparation thereof |
10/01/1991 | CA1289880C Anti-human ovarian cancer immunotoxins and methods of use thereof |
09/29/1991 | WO1991014681A1 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
09/29/1991 | WO1991014680A1 Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same |
09/29/1991 | CA2038716A1 Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide-containing preparation, stabilizing method thereof and drug stabilized thereby |
09/27/1991 | WO1991014459A1 A bifunctional dtpa-type ligand |
09/27/1991 | WO1991014442A1 Eriodictyon extract pharmaceutical compositions |
09/27/1991 | WO1991014441A1 Eriodictyon drug delivery systems |
09/27/1991 | CA2079107A1 Compositions and methods for imparting moisture to a substrate |
09/27/1991 | CA2079106A1 Drug delivery systems containing eriodictyon fluid extract as an excipient, and methods and compositions associated therewith |
09/25/1991 | EP0448300A2 Method and composition for coiontophoresis |
09/25/1991 | EP0448299A2 Composition for increased skin concentration of active agents by iontophoresis |
09/25/1991 | EP0448288A1 Pharmaceutical iodine compositions |
09/25/1991 | EP0448146A1 Stabilized gonadotropin containing preparations |
09/25/1991 | EP0448126A1 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |